SCYB.V - Scythian Biosciences Corp.

TSXV - TSXV Delayed Price. Currency in CAD
3.36
+0.21 (+6.67%)
At close: 3:58PM EDT
Stock chart is not supported by your current browser
Previous Close3.15
Open3.69
Bid3.55 x 0
Ask3.55 x 0
Day's Range3.21 - 3.69
52 Week Range1.01 - 9.92
Volume158,865
Avg. Volume118,420
Market Cap98.561M
Beta2.41
PE Ratio (TTM)N/A
EPS (TTM)-1.34
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire17 days ago

    Scythian Biosciences Announces Name Change to SOL Global Investments Corp.

    Scythian Biosciences Corp. (the "Company" or “Scythian”) (SCYB.V) (9SB.F) (OTC – Nasdaq Intl:SCCYF) is pleased to announce that the Company will be changing its name from “Scythian Biosciences Corp.” to “SOL Global Investments Corp.” The Company will put the name change resolution before its shareholders at its next scheduled annual general meeting, which will be sometime in August 2018. The name change is also subject to approval by the TSX Venture Exchange (“TSXV”).

  • GlobeNewswirelast month

    Scythian Biosciences Announces ColCanna SAS’ Receipt of Licence to Cultivate and Import CBD into Colombia

    Scythian Biosciences Corp. (the "Company" or “Scythian”) (SCYB.V) (9SB.F) (OTC – Nasdaq Intl:SCCYF) is pleased to announce that Colombian-based ColCanna SAS (“ColCanna”), a company that Scythian is in the process of acquiring, has received a licence for the cultivation and importation of non-psychoactive cannabis (“CBD”) by the Ministry of Justice and Law of Colombia. Additionally, ColCanna has entered into an exclusive international supply agreement for Colombia (the “Supply Agreement”) with Aphria Inc. (APH.TO) (“Aphria”), a prominent Canadian low-cost producer of medical cannabis.

  • GlobeNewswirelast month

    Scythian Biosciences Announces Binding Agreement for Argentinian Acquisition of ABP

    Scythian Biosciences Corp. (the "Company" or “Scythian”) (SCYB.V) (9SB.F) (OTC – Nasdaq Intl:SCCYF) is pleased to announce that the Company has entered into a business combination agreement (the "Agreement") with MMJ International Investments Inc. (“MMJ” or “MMJ International”), owner of Argentina-based ABP S.A. (“ABP”), a pharmaceutical import and distribution company with a license to import, sell and distribute medical products and derivatives in Argentina. ABP also holds a license to import CBD oil into Argentina (the “License”).  Under the terms of the Agreement, Scythian will acquire all of the issued and outstanding common shares of MMJ by way of a three-cornered amalgamation (the “Transaction”) whereby MMJ will amalgamate with a wholly-owned subsidiary of the Company.

  • GlobeNewswire2 months ago

    Scythian Biosciences Announces Licensing Agreement With Isodiol International Inc.

    Scythian Biosciences Corp. (the "Company" or “Scythian”) (SCYB.V) (9SB.F) (OTC – Nasdaq Intl:SCCYF) is pleased to announce that it has signed a letter agreement (the “Agreement”) with Isodiol International Inc. (“Isodiol”), (CSE:ISOL) a market leader in pharmaceutical grade phytochemical compounds and an industry leader in the manufacturing and development of CBD consumer products, to import and distribute Isodiol products to certain countries in the Caribbean, Central America, and South America, including Argentina, Colombia and Jamaica. Scythian has also committed to invest $2,000,000 into Isodiol, in exchange for 2,739,726 units in Isodiol (“Units”), with each Unit consisting of one common share of Isodiol (“Common Share”) and one whole Common Share purchase warrant (“Warrant”).

  • GlobeNewswire2 months ago

    Scythian Announces Marigold’s Exclusive Agreement with Jamaica’s Peter Tosh Museum

    Scythian Biosciences Corp. (the "Company" or “Scythian”) (SCYB.V) (9SB.F) (OTC – Nasdaq Intl:SCCYF) is pleased to announce that Jamaica-based Marigold Projects Jamaica Ltd. (“Marigold”), a company that Scythian is in the process of acquiring a 49% interest in, has signed an exclusive sponsorship agreement with the world-renowned Peter Tosh Museum (the “Museum”) in Kingston, Jamaica. Under the terms of the agreement, Marigold will become the exclusive cannabis dispensary partner of the Museum.

  • GlobeNewswire2 months ago

    Scythian Biosciences Announces Extension of Letter of Intent

    Scythian Biosciences Corp. (the "Company" or “Scythian”) (SCYB.V) (9SB.F) (OTC – Nasdaq Intl:SCCYF) announced today that the Company has signed an agreement to extend its previously announced letter of intent to acquire MMJ International Investments Inc. (“MMJ”), the sole shareholder of ABP S.A. (“ABP”), an Argentina-based pharmaceutical import and distribution company pursuing medical cannabis opportunities in South America. The agreement extends the deadline for negotiating and entering into a definitive agreement with MMJ from April 30, 2018, to May 11, 2018.

  • GlobeNewswire2 months ago

    Scythian Biosciences Corp. Announces the Appointment of European Cannabis Leader Rob Reid of Prohibition Partners as CEO

    Scythian Biosciences Corp. (the "Company" or “Scythian”) (SCYB.V) (9SB.F) (OTC – Nasdaq Intl:SCCYF) announced today that it has appointed Rob Reid as CEO, George Scorsis as Chairman of the Board of Directors and that it has reinstated Roger Rai to the Board of Directors effective April 25, 2018. In connection with these appointments, Jonathan Gilbert will be stepping down as CEO and will take on a new role of managing the University of Miami partnership. “I am extremely excited to be appointed as CEO of Scythian,” said Rob Reid.

  • GlobeNewswire2 months ago

    Scythian Announces ABP S.A.’s First Purchase Order with Aphria Inc.

    Scythian Biosciences Corp. (the "Company" or “Scythian”) (SCYB.V) (9SB.F) (OTC – Nasdaq Intl:SCCYF) is pleased to announce that Argentina-based ABP S.A. (“ABP”), a pharmaceutical import and distribution company that Scythian is in the process of acquiring, has received its first purchase order  (the “Order”) of CBD oil, which is to be fulfilled under the supply agreement with Aphria Inc. (APH.TO) (“Aphria”), a prominent Canadian producer of medical cannabis. The Order is for Aphria’s renowned CBD oil strain, Rideau.

  • GlobeNewswire2 months ago

    Scythian Biosciences Appoints Gabriel Meneses as Vice President of Latin America and Caribbean

    TORONTO, April 17, 2018-- Scythian Biosciences Corp. is pleased to announce the appointments of Gabriel Meneses and Roberto Pérez Ruiz to the Company’ s senior leadership team and the engagement of Houston, ...

  • GlobeNewswire2 months ago

    Scythian Biosciences Announces Details of 4-for-1 Stock Split

    TORONTO, April 10, 2018-- Scythian Biosciences Corp. is pleased to announce details of the 4- for-1 stock split previously announced by the Company on March 12, 2018. Pursuant to the Stock Split, each ...

  • CNW Group2 months ago

    IIROC Trading Resumption - SCYB

    VANCOUVER , April 9, 2018 /CNW/ - Trading resumes in: Company: Scythian Biosciences Corp. TSX-Venture Symbol: SCYB Resumption (ET): 14:30 IIROC can make a decision to impose a temporary suspension (halt) ...

  • GlobeNewswire2 months ago

    Scythian Poised to Enter Argentina Cannabis Market

    ABP S.A., Sets Milestone Receiving Argentina’ s First & Only Cannabis License. Scythian Sets Pace for Argentina Cannabis Market Through Aphria Partnership and Exclusive Agreements With Country’ s Largest ...

  • CNW Group2 months ago

    IIROC Trading Halt - SCYB

    VANCOUVER , April 9, 2018 /CNW/ - The following issues have been halted by IIROC: Company: Scythian Biosciences Corp TSX-Venture Symbol: SCYB Reason: At the Request of the Company Pending News Halt Time ...

  • CNW Group2 months ago

    IIROC Trading Resumption - SCYB

    VANCOUVER , April 9, 2018 /CNW/ - Trading resumes in: Company: Scythian Biosciences Corp TSX-Venture Symbol: SCYB Resumption (ET): 10:00 AM IIROC can make a decision to impose a temporary suspension (halt) ...

  • GlobeNewswire2 months ago

    Scythian Biosciences Corp. Announces Progression of Global Expansion Efforts with Letter of Intent to Acquire MMJ Colombia Partners Inc.

    –Closing of the Acquisition will strengthen Scythian’ s Latin American platform with three Colombian cannabis licences including for cultivation of CBD, THC and extraction of cannabis derivatives–. Alejandro ...

  • CNW Group2 months ago

    IIROC Trading Halt - SCYB

    VANCOUVER , April 9, 2018 /CNW/ - The following issues have been halted by IIROC: Company: Scythian Biosciences Corp TSX-Venture Symbol: SCYB Reason: At the Request of the Company Pending News Halt Time ...

  • GlobeNewswire3 months ago

    Scythian Biosciences Announces Extension of Letter of Intent

    TORONTO, March 29, 2018-- Scythian Biosciences Corp. announced today that the Company has signed an agreement to extend its previously announced letter of intent to acquire MMJ International Investments ...

  • CNW Group3 months ago

    IIROC Trading Resumption - SCYB

    VANCOUVER , March 22, 2018 /CNW/ - Trading resumes in: Company: Scythian Biosciences Corp. TSX-Venture Symbol: SCYB Resumption (ET): 11:45 AM IIROC can make a decision to impose a temporary suspension ...

  • PR Newswire3 months ago

    IIROC Trading Resumption - SCYB

    VANCOUVER , March 22, 2018 /CNW/ - Trading resumes in: Company: Scythian Biosciences Corp. TSX-Venture Symbol: SCYB Resumption (ET): 11:45 AM IIROC can make a decision to impose a temporary suspension ...

  • CNW Group3 months ago

    IIROC Trading Halt - SCYB

    VANCOUVER , March 22, 2018 /CNW/ - The following issues have been halted by IIROC: Company: Scythian Biosciences Corp. TSX-Venture Symbol: SCYB Reason: At the Request of the Company Pending News Halt Time ...

  • PR Newswire3 months ago

    IIROC Trading Halt - SCYB

    VANCOUVER , March 22, 2018 /CNW/ - The following issues have been halted by IIROC: Company: Scythian Biosciences Corp. TSX-Venture Symbol: SCYB Reason: At the Request of the Company Pending News Halt Time ...